NCT04072731View on ClinicalTrials.gov

SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

January 16, 2016

Primary Completion Date

July 30, 2017

Study Completion Date

January 1, 2018

Conditions
Thyroid Cancer
Interventions
OTHER

pathologic

All the enrolled patients were treated with whole resection and diagnosed by the Pathology Department based on the pathological evidence.

Trial Locations (1)

410078

the Affiliated Cancer Hospital of Xiangya Medical School, Changsha

All Listed Sponsors
lead

People's Hospital of Zhengzhou University

OTHER

NCT04072731 - SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer | Biotech Hunter | Biotech Hunter